SS-31
Elamipretide, MTP-131
Overview
SS-31 is a novel mitochondrial-targeted peptide designed to stabilize cardiolipin in the inner mitochondrial membrane. It is primarily researched for its potential to improve mitochondrial function and mitigate oxidative stress in various tissues.
Research Summary
Research Summary
SS-31 (Elamipretide) represents a breakthrough in the field of mitochondrial medicine. Unlike traditional antioxidants that attempt to neutralize free radicals after they are formed, SS-31 targets the source of mitochondrial dysfunction. The peptide is structurally designed to possess a unique aromatic-cationic motif that allows it to easily penetrate cell membranes and accumulate selectively in the inner mitochondrial membrane (IMM). Once there, it binds to cardiolipin, a critical phospholipid responsible for maintaining the structural integrity of the mitochondrial cristae.
In disease states or during aging, cardiolipin is prone to oxidation by cytochrome c, which leads to mitochondrial membrane breakdown and the release of reactive oxygen species (ROS). SS-31 prevents this peroxidation, keeping the mitochondrial electron transport chain working efficiently. Research indicates that this stabilization leads to improved ATP production and reduced apoptosis (programmed cell death) in energy-demanding tissues such as the heart, kidneys, and skeletal muscle. Extensive studies have explored its application in cardiovascular conditions, such as ischemia-reperfusion injury, where it has demonstrated the ability to preserve tissue health after blood flow restoration. Furthermore, researchers are examining its efficacy in neurodegenerative diseases and muscle wasting conditions, as mitochondrial decline is a common denominator in these pathologies. By restoring mitochondrial homeostasis, SS-31 offers a promising therapeutic platform for diseases characterized by oxidative damage and metabolic crisis.
Mechanism of Action
The mechanism of SS-31 centers on its selective association with cardiolipin. By binding to cardiolipin, the peptide prevents the conversion of cytochrome c into a peroxidase enzyme, which is a major contributor to mitochondrial ROS production.
By effectively shielding the IMM from oxidative damage, SS-31 facilitates optimal coupling of the electron transport chain. This improves the efficiency of ATP synthesis and suppresses the opening of the mitochondrial permeability transition pore (mPTP), a structure that, when opened, leads to cell death. This dual action of boosting energy output while preventing cell damage makes it a unique target for metabolic and degenerative research.
Common Discussion Topics
This compound is for research purposes only and is not intended for human consumption or medical treatment.
Discussion
Commenting as guest — your email won't be shown publicly.
No comments yet. Be the first to start the discussion!
Stay Updated
Get the latest peptide research insights delivered to your inbox.